896 related articles for article (PubMed ID: 25440608)
1. The next generation of antibody drug conjugates.
Mack F; Ritchie M; Sapra P
Semin Oncol; 2014 Oct; 41(5):637-52. PubMed ID: 25440608
[TBL] [Abstract][Full Text] [Related]
2. Site-specific antibody drug conjugates for cancer therapy.
Panowski S; Bhakta S; Raab H; Polakis P; Junutula JR
MAbs; 2014; 6(1):34-45. PubMed ID: 24423619
[TBL] [Abstract][Full Text] [Related]
3. Antibody-drug conjugates: the chemistry behind empowering antibodies to fight cancer.
Drachman JG; Senter PD
Hematology Am Soc Hematol Educ Program; 2013; 2013():306-10. PubMed ID: 24319196
[TBL] [Abstract][Full Text] [Related]
4. Antibody-targeted drugs and drug resistance--challenges and solutions.
Shefet-Carasso L; Benhar I
Drug Resist Updat; 2015 Jan; 18():36-46. PubMed ID: 25476546
[TBL] [Abstract][Full Text] [Related]
5. Antibody drug conjugates.
Teicher BA
Curr Opin Oncol; 2014 Sep; 26(5):476-83. PubMed ID: 25024051
[TBL] [Abstract][Full Text] [Related]
6. Antibody-Drug Conjugates (ADCs) for Personalized Treatment of Solid Tumors: A Review.
Lambert JM; Morris CQ
Adv Ther; 2017 May; 34(5):1015-1035. PubMed ID: 28361465
[TBL] [Abstract][Full Text] [Related]
7. Strategies and challenges for the next generation of antibody-drug conjugates.
Beck A; Goetsch L; Dumontet C; Corvaïa N
Nat Rev Drug Discov; 2017 May; 16(5):315-337. PubMed ID: 28303026
[TBL] [Abstract][Full Text] [Related]
8. Antibody-drug conjugates: current status and future directions.
Perez HL; Cardarelli PM; Deshpande S; Gangwar S; Schroeder GM; Vite GD; Borzilleri RM
Drug Discov Today; 2014 Jul; 19(7):869-81. PubMed ID: 24239727
[TBL] [Abstract][Full Text] [Related]
9. Preclinical and clinical pharmacokinetic/pharmacodynamic considerations for antibody-drug conjugates.
Sapra P; Betts A; Boni J
Expert Rev Clin Pharmacol; 2013 Sep; 6(5):541-55. PubMed ID: 23978126
[TBL] [Abstract][Full Text] [Related]
10. Antibody-Drug Conjugates: A Clinical Pharmacy Perspective on an Emerging Cancer Therapy.
Jerjian TV; Glode AE; Thompson LA; O'Bryant CL
Pharmacotherapy; 2016 Jan; 36(1):99-116. PubMed ID: 26799352
[TBL] [Abstract][Full Text] [Related]
11. [Antibody-drug conjugates: a new therapeutic class?].
Chofflon I; Dietrich PY; Thang NN
Rev Med Suisse; 2013 May; 9(387):1080-2, 1084-6. PubMed ID: 23757915
[TBL] [Abstract][Full Text] [Related]
12. Antibody-drug conjugates: an emerging concept in cancer therapy.
Chari RV; Miller ML; Widdison WC
Angew Chem Int Ed Engl; 2014 Apr; 53(15):3796-827. PubMed ID: 24677743
[TBL] [Abstract][Full Text] [Related]
13. [The growing field of immunoconjugates in oncology. A successful link(er) between antibodies and small cytotoxic molecules].
Vigne E; Sassoon I
Med Sci (Paris); 2014 Oct; 30(10):855-63. PubMed ID: 25311020
[TBL] [Abstract][Full Text] [Related]
14. Drug conjugates such as Antibody Drug Conjugates (ADCs), immunotoxins and immunoliposomes challenge daily clinical practice.
Janthur WD; Cantoni N; Mamot C
Int J Mol Sci; 2012 Nov; 13(12):16020-45. PubMed ID: 23443108
[TBL] [Abstract][Full Text] [Related]
15. Site-specific trastuzumab maytansinoid antibody-drug conjugates with improved therapeutic activity through linker and antibody engineering.
Pillow TH; Tien J; Parsons-Reponte KL; Bhakta S; Li H; Staben LR; Li G; Chuh J; Fourie-O'Donohue A; Darwish M; Yip V; Liu L; Leipold DD; Su D; Wu E; Spencer SD; Shen BQ; Xu K; Kozak KR; Raab H; Vandlen R; Lewis Phillips GD; Scheller RH; Polakis P; Sliwkowski MX; Flygare JA; Junutula JR
J Med Chem; 2014 Oct; 57(19):7890-9. PubMed ID: 25191794
[TBL] [Abstract][Full Text] [Related]
16. Sortase Enzyme-Mediated Generation of Site-Specifically Conjugated Antibody Drug Conjugates with High In Vitro and In Vivo Potency.
Beerli RR; Hell T; Merkel AS; Grawunder U
PLoS One; 2015; 10(7):e0131177. PubMed ID: 26132162
[TBL] [Abstract][Full Text] [Related]
17. Current methods for the synthesis of homogeneous antibody-drug conjugates.
Sochaj AM; Świderska KW; Otlewski J
Biotechnol Adv; 2015 Nov; 33(6 Pt 1):775-84. PubMed ID: 25981886
[TBL] [Abstract][Full Text] [Related]
18. World Antibody Drug Conjugate Summit Europe: February 21-23, 2011; Frankfurt, Germany.
Beck A; Senter P; Chari R
MAbs; 2011; 3(4):331-7. PubMed ID: 21691144
[TBL] [Abstract][Full Text] [Related]
19. Natural products as exquisitely potent cytotoxic payloads for antibody- drug conjugates.
Gromek SM; Balunas MJ
Curr Top Med Chem; 2015; 14(24):2822-34. PubMed ID: 25487009
[TBL] [Abstract][Full Text] [Related]
20. Antibody-drug conjugates in cancer therapy.
Sievers EL; Senter PD
Annu Rev Med; 2013; 64():15-29. PubMed ID: 23043493
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
